Non-opioid pain products
The company develops and commercializes non-opioid pain management products.
Source: LinkedIn company description · Retrieved October 13, 2026
Scilex Holding Company develops and commercializes non-opioid pain management products.
Its lead product, ZTlido, is a marketed prescription lidocaine topical product approved by the U.S. FDA for pain associated with post-herpetic neuralgia. The company acquired FDA-approved non-opioid pain products GLOPERBA, indicated to prevent gout flares in adults, and ELYXYB, indicated for acute migraine treatment in adults with or without aura.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops and commercializes non-opioid pain management products.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.